S2Medical AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a S2M.ST research report →
Companywww.s2m.se
S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds. It offers INSTAQRETT, a sterile single use mechanical debridement tool; EPIPROTECT SafeStop for blood stilling; Instagraft, a single-use medical device for the treatment of chronic and complicated wounds; EPIPROTECT tissue substitutes; and washable, waterproof, and self-adhesive bandages under the INSTABIND brand name. The company also distributes Silverlon dressings that deliver silver ions into the wound.
- CEO
- Petter Sivler
- IPO
- 2018
- Employees
- 17
- HQ
- Linköping, SE
Price Chart
Valuation
- Market Cap
- $5.39M
- P/E
- -2.35
- P/S
- 0.37
- P/B
- 0.27
- EV/EBITDA
- -1.82
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 90.31%
- Op Margin
- -15.57%
- Net Margin
- -14.73%
- ROE
- -13.05%
- ROIC
- -10.14%
Growth & Income
- Revenue
- $14.36M · -3.66%
- Net Income
- $-10,092,000 · -274.87%
- EPS
- $-0.01 · -214.56%
- Op Income
- $-2,681,000
- FCF YoY
- -100.00%
Performance & Tape
- 52W High
- $0.03
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 2.29
- Avg Volume
- 3.52M
Get TickerSpark's AI analysis on S2M.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our S2M.ST Coverage
We haven't published any research on S2M.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate S2M.ST Report →